Oncology Molecular Diagnostics Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Oncology Molecular Diagnostics Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON , UK, July 29, 2022 /EINPresswire.com/ -- According to ‘Oncology Molecular Diagnostics Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026’ published by The Business Research Company, the oncology molecular diagnostics market size is expected to grow from $3.22 billion in 2021 to $3.66 billion in 2022 at a compound annual growth rate (CAGR) of 13.6%. The global oncology molecular diagnostic market size is expected to grow to $6.34 billion in 2026 at a CAGR of 14.7%. The rise in the number of cancer cases across the globe is likely to contribute to the oncology molecular diagnostics industry growth.

Want to learn more on the oncology molecular diagnostics market growth? Request for a Sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3457&type=smp

The oncology molecular diagnostics market consists of sales of molecular diagnostic instruments, kits, and reagents used for diagnosing cancers and related services by entities (organizations, sole traders, and partnerships) that produce molecular diagnostic equipment for diagnosing cancer. Molecular diagnostics are tests that diagnose genetic information, proteins, or related molecules and provide health or disease information. This study is most usually performed on blood, saliva, or tumor tissue samples.

Global Oncology Molecular Diagnostics Market Trends
The advanced technology in genomics is a key trend in the oncology molecular diagnostics market. Advancements in cancer genome sequencing technology, computational analysis, tumor models, and innovation of modern cancer research methods promote early detection of cancer and its mutation.

Global Oncology Molecular Diagnostics Market Segments
The global oncology molecular diagnostics market is segmented:
By Product: Instruments, Reagents, Others
By Technology: Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Others
By End-User: Hospitals, Diagnostic Centers, Academic and Research Institutes, Others
By Geography: The global oncology molecular diagnostics market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read more on the global oncology molecular diagnostics market report at:
https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Oncology Molecular Diagnostics Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides oncology molecular diagnostics market overviews, oncology molecular diagnostics market analysis and forecasts market size and growth for the global oncology molecular diagnostics market, oncology molecular diagnostics market share, oncology molecular diagnostics market segments and geographies, oncology molecular diagnostics market players, oncology molecular diagnostics market leading competitor revenues, profiles and market shares. The oncology molecular diagnostics market report identifies top countries and segments for opportunities and strategies based on market trends and key competitors’ approaches.

TBRC’s Oncology Molecular Diagnostics Global Market Report 2022 includes information on the following:

Data Segmentations: Market Size, Global, By Region and Country, Historic and Forecast, and Growth Rates for 60 Geographies

Key Market Players: Abbott Diagnostics, Becton Dickinson, Cepheid, Danaher Corporation, Beckman Coulter, Leica Biosystems, Gen-Probe (Hologic), Qiagen N.V., Roche Diagnostics, and Siemens Healthcare.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

And so much more.

Looking for something else? Here is a list of similar reports by The Business Research Company:

Oncology Devices Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Oncology Biosimilars Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

Oncology Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report

About The Business Research Company

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Market Research Products, Services, Solutions For Your Business - TBRC

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.